Sinovac Biotech Ltd - Understand $sva stock

$SVA Market Cap: $639.9 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$850.1M

TTM

Gross Margin

20.26%

TTM

Net Earnings

-$490.4M

TTM

Current Assets

$11.15B

Q2 2024

Current Liabilities

$978.5M

Q2 2024

Current Ratio

1139.38%

Q2 2024

Total Assets

$12.90B

Q2 2024

Total Liabilities

$4.248B

Q2 2024

Book Value

$8.649B

Q2 2024

Cash

$1.072B

Q2 2024

P/E

-1.305

Nov 11, 2024 EST

Free Cash Flow

-$624.2M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Revenue	$448.3M	$1.493B	$19.37B	$510.6M	$246.1M	$229.7M	$174.3M	$72.40M	$67.40M	$62.90M	$71.80M	$49.20M	$56.80M	$33.40M	$84.20M	$46.50M	$33.50M	$15.40M	$8.600M	$6.500M	$2.800M	$600.0K	$0.00
YoY Change	-69.97%	-92.3%	3694.54%	107.48%	7.14%	31.78%	140.75%	7.42%	7.15%	-12.4%	45.93%	-13.38%	70.06%	-60.33%	81.08%	38.81%	117.53%	79.07%	32.31%	132.14%	366.67%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Revenue	$448.3M	$1.493B	$19.37B	$510.6M	$246.1M	$229.7M	$174.3M	$72.40M	$67.40M	$62.90M	$71.80M	$49.20M	$56.80M	$33.40M	$84.20M	$46.50M	$33.50M	$15.40M	$8.600M	$6.500M	$2.800M	$600.0K	$0.00
Cost Of Revenue	$181.5M	$684.5M	$1.072B	$67.20M	$32.50M	$24.70M	$20.20M	$22.40M	$18.40M	$15.50M	$20.50M	$19.10M	$21.10M	$16.70M	$20.10M	$9.900M	$6.500M	$4.200M	$2.300M	$1.900M	$1.100M	$300.0K	$0.00
Gross Profit	$266.8M	$808.3M	$18.30B	$443.4M	$213.6M	$204.9M	$154.1M	$50.00M	$49.00M	$47.50M	$51.30M	$30.10M	$35.70M	$16.70M	$64.10M	$36.60M	$27.00M	$11.10M	$6.300M	$4.500M	$1.800M	$400.0K	$0.00
Gross Profit Margin	59.51%	54.15%	94.47%	86.84%	86.79%	89.2%	88.41%	69.06%	72.7%	75.52%	71.45%	61.18%	62.85%	50.0%	76.13%	78.71%	80.6%	72.08%	73.26%	69.23%	64.29%	66.67%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Selling, General & Admin	$466.3M	$823.5M	$594.1M	$179.2M	$121.2M	$137.8M	$88.30M	$43.40M	$37.40M	$34.70M	$33.10M	$32.40M	$23.60M	$20.80M	$18.20M	$17.30M	$12.00M	$9.800M	$10.30M	$8.800M	$1.700M	$800.0K	$100.0K
YoY Change	-43.38%	38.61%	231.55%	47.85%	-12.05%	56.06%	103.46%	16.04%	7.78%	4.83%	2.16%	37.29%	13.46%	14.29%	5.2%	44.17%	22.45%	-4.85%	17.05%	417.65%	112.5%	700.0%
% of Gross Profit	174.81%	101.89%	3.25%	40.41%	56.74%	67.25%	57.3%	86.8%	76.33%	73.05%	64.52%	107.64%	66.11%	124.55%	28.39%	47.27%	44.44%	88.29%	163.49%	195.56%	94.44%	200.0%
Research & Development	$344.5M	$442.1M	$155.0M	$48.80M	$24.30M	$21.90M	$20.50M	$12.60M	$9.500M	$10.90M	$8.100M	$17.00M	$9.000M	$6.600M	$3.100M	$2.700M	$1.000M	$300.0K	$200.0K	$300.0K	$600.0K	$500.0K	$0.00
YoY Change	-22.07%	185.16%	217.7%	100.82%	10.96%	6.83%	62.7%	32.63%	-12.84%	34.57%	-52.35%	88.89%	36.36%	112.9%	14.81%	170.0%	233.33%	50.0%	-33.33%	-50.0%	20.0%
% of Gross Profit	129.15%	54.7%	0.85%	11.01%	11.38%	10.69%	13.3%	25.2%	19.39%	22.95%	15.79%	56.48%	25.21%	39.52%	4.84%	7.38%	3.7%	2.7%	3.17%	6.67%	33.33%	125.0%
Depreciation & Amortization	$140.5M	$153.8M	$86.83M	$4.000M	$4.800M	$5.100M	$4.800M	$5.300M	$6.600M	$8.100M	$6.400M	$4.500M	$4.800M	$4.200M	$2.200M	$1.800M	$1.400M	$1.300M	$1.100M	$800.0K	$700.0K	$400.0K	$0.00
YoY Change	-8.68%	77.15%	2070.8%	-16.67%	-5.88%	6.25%	-9.43%	-19.7%	-18.52%	26.56%	42.22%	-6.25%	14.29%	90.91%	22.22%	28.57%	7.69%	18.18%	37.5%	14.29%	75.0%
% of Gross Profit	52.66%	19.03%	0.47%	0.9%	2.25%	2.49%	3.11%	10.6%	13.47%	17.05%	12.48%	14.95%	13.45%	25.15%	3.43%	4.92%	5.19%	11.71%	17.46%	17.78%	38.89%	100.0%
Operating Expenses	$869.8M	$1.274B	$748.4M	$227.6M	$144.7M	$159.5M	$108.7M	$49.00M	$45.30M	$45.40M	$41.20M	$49.10M	$31.90M	$28.80M	$21.90M	$20.80M	$13.60M	$10.70M	$11.10M	$9.500M	$2.700M	$1.500M	$100.0K
YoY Change	-31.75%	70.27%	228.84%	57.29%	-9.28%	46.73%	121.84%	8.17%	-0.22%	10.19%	-16.09%	53.92%	10.76%	31.51%	5.29%	52.94%	27.1%	-3.6%	16.84%	251.85%	80.0%	1400.0%
Operating Profit	-$603.0M	-$466.1M	$17.55B	$215.8M	$68.90M	$45.40M	$45.40M	$1.000M	$3.700M	$2.100M	$10.10M	-$19.00M	$3.800M	-$12.10M	$42.20M	$15.80M	$13.40M	$400.0K	-$4.800M	-$5.000M	-$900.0K	-$1.100M	-$100.0K
YoY Change	29.39%	-102.66%	8034.49%	213.21%	51.76%	0.0%	4440.0%	-72.97%	76.19%	-79.21%	-153.16%	-600.0%	-131.4%	-128.67%	167.09%	17.91%	3250.0%	-108.33%	-4.0%	455.56%	-18.18%	1000.0%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Interest Expense	$82.85M	$189.6M	$99.73M	$500.0K	$1.300M	$900.0K	-$400.0K	-$1.000M	-$800.0K	-$700.0K	-$900.0K	$1.600M	$1.000M	$0.00	-$400.0K	-$500.0K	-$300.0K	$0.00	$0.00	$0.00	-$200.0K	$0.00	$100.0K
YoY Change	-56.29%	90.06%	19846.4%	-61.54%	44.44%	-325.0%	-60.0%	25.0%	14.29%	-22.22%	-156.25%	60.0%		-100.0%	-20.0%	66.67%				-100.0%		-100.0%
% of Operating Profit			0.57%	0.23%	1.89%	1.98%	-0.88%	-100.0%	-21.62%	-33.33%	-8.91%		26.32%		-0.95%	-3.16%	-2.24%	0.0%
Other Income/Expense, Net	$367.1M	$301.8M	-$89.95M	$500.0K	$900.0K	$300.0K	$0.00	$100.0K	-$200.0K	$1.200M	$300.0K	-$100.0K	$300.0K	$100.0K	$0.00	$0.00
YoY Change	21.67%	-435.47%	-18089.6%	-44.44%	200.0%		-100.0%	-150.0%	-116.67%	300.0%	-400.0%	-133.33%	200.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001
Pretax Income	-$153.0M	$25.24M	$17.56B	$216.6M	$70.80M	$46.60M	$45.00M	-$400.0K	$2.800M	$2.300M	$9.400M	-$19.60M	$4.700M	-$13.30M	$41.60M	$15.20M	$13.20M	$400.0K	-$5.000M	-$5.000M	-$1.100M	-$1.200M	-$100.0K
YoY Change	-706.36%	-99.86%	8008.51%	205.93%	51.93%	3.56%	-11350.0%	-114.29%	21.74%	-75.53%	-147.96%	-517.02%	-135.34%	-131.97%	173.68%	15.15%	3200.0%	-108.0%	0.0%	354.55%	-8.33%	1100.0%
Income Tax	$105.3M	-$62.89M	$3.104B	$31.40M	$5.600M	$10.50M	$8.300M	$2.700M	$3.000M	$2.100M	-$2.200M	-$900.0K	$5.100M	-$700.0K	$11.10M	$3.000M	$2.000M	$100.0K	$200.0K	-$800.0K	$0.00	$0.00	$0.00
% Of Pretax Income		-249.2%	17.67%	14.5%	7.91%	22.53%	18.44%		107.14%	91.3%	-23.4%		108.51%		26.68%	19.74%	15.15%	25.0%
Net Earnings	-$99.92M	$113.9M	$8.467B	$110.4M	$44.90M	$21.80M	$25.80M	-$600.0K	-$1.400M	-$1.500M	$7.400M	-$14.90M	-$800.0K	-$8.500M	$20.00M	$8.000M	$7.700M	-$700.0K	-$5.100M	-$4.700M	-$900.0K	-$1.200M	-$100.0K
YoY Change	-187.75%	-98.66%	7569.82%	145.88%	105.96%	-15.5%	-4400.0%	-57.14%	-6.67%	-120.27%	-149.66%	1762.5%	-90.59%	-142.5%	150.0%	3.9%	-1200.0%	-86.27%	8.51%	422.22%	-25.0%	1100.0%
Net Earnings / Revenue	-22.29%	7.63%	43.7%	21.62%	18.24%	9.49%	14.8%	-0.83%	-2.08%	-2.38%	10.31%	-30.28%	-1.41%	-25.45%	23.75%	17.2%	22.99%	-4.55%	-59.3%	-72.31%	-32.14%	-200.0%
Basic Earnings Per Share	-$1.06	$1.08	$85.20	$1.06
Diluted Earnings Per Share	-$1.06	$1.00	$74.27M	$971.0K	$409.3K	$335.4K	$451.8K	-$10.54K	-$24.87K	-$26.93K	$132.6K	-$271.4K	-$14.65K	-$160.1K	$465.1K	$188.2K	$189.7K	-$18.32K	-$140.1K	-$143.7K	-$44.78K	-$75.47K	-$13.33K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Cash & Short-Term Investments	$11.22B	$11.31B	$13.42B	$1.176B	$203.0M	$177.1M	$114.4M	$62.40M	$63.80M	$91.30M	$107.2M	$91.20M	$104.3M	$103.1M	$82.30M	$32.90M	$17.10M	$9.200M	$7.400M	$2.600M	$1.400M	$300.0K
YoY Change	-0.79%	-15.67%	1040.47%	479.46%	14.62%	54.81%	83.33%	-2.19%	-30.12%	-14.83%	17.54%	-12.56%	1.16%	25.27%	150.15%	92.4%	85.87%	24.32%	184.62%	85.71%	366.67%
Cash & Equivalents	$1.270B	$4.278B	$11.61B	$1.041B	$152.7M	$158.2M	$114.4M	$62.40M	$63.80M	$91.30M	$107.2M	$91.20M	$104.3M	$101.6M	$75.00M	$32.90M	$17.10M	$9.200M	$7.400M	$2.600M	$1.400M	$300.0K
Short-Term Investments	$9.953B	$7.035B	$1.806B	$135.2M	$50.30M	$18.90M								$1.500M	$7.300M	$0.00
Other Short-Term Assets	$16.79M	$23.50M	$171.9M	$24.70M	$5.100M	$4.500M	$3.600M	$4.400M	$7.000M	$4.100M	$3.800M	$1.100M	$1.800M	$3.600M	$1.900M	$2.100M	$1.400M	$700.0K	$900.0K	$800.0K	$0.00	$0.00
YoY Change	-28.55%	-86.33%	595.92%	384.31%	13.33%	25.0%	-18.18%	-37.14%	70.73%	7.89%	245.45%	-38.89%	-50.0%	89.47%	-9.52%	50.0%	100.0%	-22.22%	12.5%
Inventory	$139.9M	$180.7M	$375.5M	$105.8M	$27.80M	$25.10M	$19.60M	$14.10M	$18.70M	$18.70M	$14.30M	$10.50M	$8.100M	$14.50M	$9.600M	$6.500M	$3.700M	$2.100M	$800.0K	$500.0K	$1.000M	$1.400M
Prepaid Expenses
Receivables	$426.0M	$497.0M	$923.8M	$250.6M	$112.1M	$73.00M	$64.70M	$48.50M	$38.30M	$39.90M	$31.30M	$22.70M	$16.90M	$25.40M	$25.30M	$19.40M	$17.00M	$9.700M	$7.200M	$4.500M	$1.500M	$500.0K
Other Receivables	$24.71M	$112.5M	$28.60M	$2.900M	$1.600M	$4.500M	$1.500M	$1.300M	$700.0K	$800.0K	$600.0K	$700.0K	$900.0K	$400.0K	$200.0K	$400.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$11.83B	$12.13B	$14.92B	$1.560B	$349.6M	$284.2M	$203.9M	$130.7M	$128.5M	$154.8M	$157.3M	$126.3M	$132.0M	$147.0M	$119.3M	$61.30M	$39.20M	$21.70M	$16.30M	$8.500M	$4.000M	$2.100M
YoY Change	-2.44%	-18.7%	855.91%	346.31%	23.01%	39.38%	56.01%	1.71%	-16.99%	-1.59%	24.54%	-4.32%	-10.2%	23.22%	94.62%	56.38%	80.65%	33.13%	91.76%	112.5%	90.48%
Property, Plant & Equipment	$1.025B	$1.052B	$1.019B	$284.2M	$80.90M	$70.90M	$76.40M	$66.90M	$63.90M	$66.20M	$68.00M	$69.20M	$75.60M	$64.00M	$22.30M	$19.30M	$15.90M	$13.00M	$12.50M	$10.00M	$7.500M	$7.600M
YoY Change	-2.59%	3.31%	258.44%	251.3%	14.1%	-7.2%	14.2%	4.69%	-3.47%	-2.65%	-1.73%	-8.47%	18.13%	187.0%	15.54%	21.38%	22.31%	4.0%	25.0%	33.33%	-1.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$684.3M	$661.4M	$655.8M
YoY Change	3.45%	0.85%
Other Assets	$109.5M	$264.7M	$157.1M	$55.40M	$21.70M	$14.70M	$18.90M	$13.70M	$10.50M	$17.10M	$14.70M	$12.20M	$6.900M	$2.000M	$3.200M	$1.500M	$1.000M	$600.0K	$700.0K	$900.0K	$0.00
YoY Change	-58.64%	68.5%	183.53%	155.3%	47.62%	-22.22%	37.96%	30.48%	-38.6%	16.33%	20.49%	76.81%	245.0%	-37.5%	113.33%	50.0%	66.67%	-14.29%	-22.22%
Total Long-Term Assets	$1.827B	$1.988B	$1.833B	$341.0M	$102.7M	$85.60M	$95.30M	$80.70M	$74.40M	$83.70M	$83.40M	$82.50M	$83.90M	$67.40M	$26.20M	$21.90M	$18.20M	$15.30M	$15.00M	$13.90M	$9.800M	$10.90M
YoY Change	-8.09%	8.46%	437.56%	232.04%	19.98%	-10.18%	18.09%	8.47%	-11.11%	0.36%	1.09%	-1.67%	24.48%	157.25%	19.63%	20.33%	18.95%	2.0%	7.91%	41.84%	-10.09%
Total Assets	$13.66B	$14.11B	$16.75B	$1.901B	$452.3M	$369.8M	$299.2M	$211.4M	$202.9M	$238.5M	$240.7M	$208.8M	$215.9M	$214.4M	$145.5M	$83.20M	$57.40M	$37.00M	$31.30M	$22.40M	$13.80M	$13.00M
YoY Change
Accounts Payable	$17.29M	$19.83M	$58.59M	$30.50M	$5.800M	$5.500M	$6.800M	$1.800M	$1.700M	$3.000M	$6.100M	$2.200M	$8.000M	$3.600M	$2.700M	$1.400M	$800.0K	$700.0K	$800.0K	$0.00	$1.200M	$1.200M
YoY Change	-12.78%	-66.16%	92.1%	425.86%	5.45%	-19.12%	277.78%	5.88%	-43.33%	-50.82%	177.27%	-72.5%	122.22%	33.33%	92.86%	75.0%	14.29%	-12.5%		-100.0%	0.0%
Accrued Expenses	$258.0M	$250.3M	$537.0M	$121.9M	$32.20M	$27.20M	$32.90M	$8.900M	$9.900M	$8.500M	$8.900M	$7.700M	$5.000M	$7.100M	$6.700M	$4.300M	$4.400M	$2.400M	$900.0K
YoY Change	3.07%	-53.39%	340.53%	278.57%	18.38%	-17.33%	269.66%	-10.1%	16.47%	-4.49%	15.58%	54.0%	-29.58%	5.97%	55.81%	-2.27%	83.33%	166.67%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$10.40M	$17.70M	$8.000M	$6.800M	$2.700M	$2.400M	$2.600M	$800.0K	$2.100M
YoY Change													-100.0%	-41.24%	121.25%	17.65%	151.85%	12.5%	-7.69%	225.0%	-61.9%
Long-Term Debt Due	$76.09M	$4.651M	$4.681M	$39.10M	$12.50M	$3.300M	$18.20M	$33.60M	$24.20M	$50.00M	$19.50M	$3.300M	$4.700M
YoY Change	1535.97%	-0.64%	-88.03%	212.8%	278.79%	-81.87%	-45.83%	38.84%	-51.6%	156.41%	490.91%	-29.79%
Total Short-Term Liabilities	$1.148B	$1.092B	$2.413B	$679.6M	$87.20M	$58.20M	$92.50M	$66.30M	$58.10M	$79.80M	$49.20M	$30.20M	$39.50M	$45.80M	$51.00M	$21.30M	$20.40M	$11.90M	$8.800M	$6.700M	$3.400M	$5.300M
YoY Change	5.15%	-54.76%	255.04%	679.36%	49.83%	-37.08%	39.52%	14.11%	-27.19%	62.2%	62.91%	-23.54%	-13.76%	-10.2%	139.44%	4.41%	71.43%	35.23%	31.34%	97.06%	-35.85%
Long-Term Debt	$177.8M	$11.51M	$17.38M	$8.300M	$1.400M	$3.900M	$14.80M	$9.400M	$800.0K	$1.800M	$32.10M	$31.20M	$17.30M	$10.10M	$0.00	$2.200M	$1.400M	$3.800M	$2.700M	$200.0K	$600.0K	$0.00
YoY Change	1444.49%	-33.74%	109.35%	492.86%	-64.1%	-73.65%	57.45%	1075.0%	-55.56%	-94.39%	2.88%	80.35%	71.29%		-100.0%	57.14%	-63.16%	40.74%	1250.0%	-66.67%
Other Long-Term Liabilities	$45.78M	$57.23M	$117.8M	$90.60M	$11.50M	$15.80M	$14.70M	$6.000M	$7.500M	$15.20M	$15.80M	$18.00M	$13.80M	$10.80M	$10.00M	$2.800M	$2.700M	$0.00
YoY Change	-20.02%	-51.41%	30.0%	687.83%	-27.22%	7.48%	145.0%	-20.0%	-50.66%	-3.8%	-12.22%	30.43%	27.78%	8.0%	257.14%	3.7%
Total Long-Term Liabilities	$223.6M	$68.75M	$135.2M	$98.90M	$12.90M	$19.70M	$29.50M	$15.40M	$8.300M	$17.00M	$47.90M	$49.20M	$31.10M	$20.90M	$10.00M	$5.000M	$4.100M	$3.800M	$2.700M	$200.0K	$600.0K	$0.00
YoY Change	225.24%	-49.14%	36.66%	666.67%	-34.52%	-33.22%	91.56%	85.54%	-51.18%	-64.51%	-2.64%	58.2%	48.8%	109.0%	100.0%	21.95%	7.89%	40.74%	1250.0%	-66.67%
Total Liabilities	$4.949B	$5.193B	$7.421B	$1.155B	$158.3M	$116.3M	$148.1M	$95.60M	$81.30M	$112.0M	$112.0M	$91.00M	$86.00M	$87.90M	$74.80M	$33.50M	$27.40M	$17.80M	$13.30M	$10.00M	$8.200M	$5.300M
YoY Change	-4.71%	-30.02%	542.54%	629.56%	36.11%	-21.47%	54.92%	17.59%	-27.41%	0.0%	23.08%	5.81%	-2.16%	17.51%	123.28%	22.26%	53.93%	33.83%	33.0%	21.95%	54.72%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020
Basic Shares Outstanding	99.61M	99.50M	99.31M	98.90M
Diluted Shares Outstanding	99.61M	114.2M	114.0M	113.7M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $639.9 Million

About SINOVAC BIOTECH LTD

Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company is headquartered in Beijing, Beijing and currently employs 3,037 full-time employees. The company went IPO on 2009-11-13. The firm is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The firm's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The firm is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The firm develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.

Industry: Pharmaceutical Preparations Peers: Burning Rock Biotech Ltd Gracell Biotechnologies Inc. I-Mab